Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators

M Ashrafizadeh, A Zarrabi, K Hushmandi, F Hashemi… - Cellular signalling, 2021 - Elsevier
Cisplatin (CP) is a well-known chemotherapeutic agent with excellent clinical effects. The
anti-tumor activity of CP has been demonstrated in different cancers such as breast, cervical …

Rafting down the metastatic cascade: the role of lipid rafts in cancer metastasis, cell death, and clinical outcomes

JD Greenlee, T Subramanian, K Liu, MR King - Cancer research, 2021 - AACR
Lipid rafts are tightly packed, cholesterol-and sphingolipid-enriched microdomains within the
plasma membrane that play important roles in many pathophysiologic processes. Rafts have …

Caveolin-1 in the regulation of cell metabolism: a cancer perspective

ZC Nwosu, MP Ebert, S Dooley, C Meyer - Molecular cancer, 2016 - Springer
Abstract Caveolin-1 (CAV1) is an oncogenic membrane protein associated with endocytosis,
extracellular matrix organisation, cholesterol distribution, cell migration and signaling …

Gemcitabine resistance in pancreatic ductal adenocarcinoma

Y Binenbaum, S Na'ara, Z Gil - Drug resistance updates, 2015 - Elsevier
Pancreatic ductal adenocarcinoma (PDA) ranks fourth among cancer related deaths. The
disappointing 5-year survival rate of below 5% stems from drug resistance to all known …

Molecular markers for breast cancer: prediction on tumor behavior

BK Banin Hirata, JMM Oda… - Disease …, 2014 - Wiley Online Library
Breast cancer is one of the most common cancers with greater than 1,300,000 cases and
450,000 deaths each year worldwide. The development of breast cancer involves a …

Caveolin-1 and cancer metabolism in the tumor microenvironment: markers, models, and mechanisms

F Sotgia, UE Martinez-Outschoorn… - Annual Review of …, 2012 - annualreviews.org
Caveolins are a family of membrane-bound scaffolding proteins that compartmentalize and
negatively regulate signal transduction. Recent studies have implicated a loss of caveolin-1 …

[HTML][HTML] Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs

P Xing, S Wang, Y Cao, B Liu, F Zheng, W Guo… - Drug Resistance …, 2023 - Elsevier
Adenocarcinoma is a common type of malignant tumor, originating from glandular epithelial
cells in various organs, such as pancreas, breast, lung, stomach, colon, rectus, and prostate …

Caveolae-mediated endocytosis is critical for albumin cellular uptake and response to albumin-bound chemotherapy

M Chatterjee, E Ben-Josef, R Robb, M Vedaie, S Seum… - Cancer research, 2017 - AACR
Nab-paclitaxel, a nanoparticle conjugate of paclitaxel to human albumin, exhibits efficacy in
pancreatic cancer, non–small cell lung cancer and breast cancer. However, there is a lack of …

Caveolin-1 in tumor progression: the good, the bad and the ugly

JG Goetz, P Lajoie, SM Wiseman, IR Nabi - Cancer and metastasis reviews, 2008 - Springer
Abstract Caveolin-1 (Cav1) is a multifunctional scaffolding protein with multiple binding
partners that is associated with cell surface caveolae and the regulation of lipid raft domains …

Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer

DJ Stewart - Critical reviews in oncology/hematology, 2010 - Elsevier
While chemotherapy provides useful palliation, advanced lung cancer remains incurable
since those tumors that are initially sensitive to therapy rapidly develop acquired resistance …